Figure 3. Estimated NIH MCM Spending by Portfolio, FYs 2018–2022 (dollars in millions)
Figure 4. Estimated BARDA MCM Spending by Portfolio, FYs 2018–2022 (dollars in millions)
Table 4. Estimated BARDA MCM Spending by Funding Source, FYs 2018–2022 (dollars in millions)
Funding Source |
FY 2018 |
FY 2019 |
FY 2020 |
FY 2021 |
FY 2022 |
Total |
|---|
Advanced Research and
Development | $537 | $562 | $562 | $1,635 | $1,295 | $4,590 |
|---|
PI - PHSSEF,
Annual Appropriations | $28 | $28 | $28 | $127 | $127 | $338 |
|---|
PI - PHSSEF,
Annual No-Year | $215 | $225 | $225 | $1,415 | $1,139 | $3,218 |
|---|
PI - PHSSEF,
Sup Bal No-Year | $24 | $104 | $148 | $- | $- | $276 |
|---|
Project BioShield SRF,
No-Year | $710 | $735 | $735 | $1,040 | $1,110 | $4,330 |
|---|
Total |
$1,514
|
$1,653
|
$1,698
|
$4,217
|
$3,671
|
$12,753
|
|---|
Figure 5. Estimated BARDA ARD MCM Spending by Portfolio, FYs 2018–2022 (dollars in millions)
Figure 6. Estimated BARDA PBS MCM Spending by Portfolio, FYs 2018–2022 (dollars in millions)
Figure 7. Estimated BARDA Pandemic Influenza MCM Spending by Portfolio, FYs 2018–2022 (dollars in millions)
Figure 8. Estimated SNS MCM Spending by Portfolio, FYs 2018–2022 (dollars in millions)
Figure 9. Estimated FDA MCM Spending by Portfolio, FYs 2018–2022 (dollars in millions)
<< Previous ---------
Top of Page
